AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 25 filers reported holding AERPIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $46,000 | +39.4% | 35,500 | -41.8% | 0.00% | – |
| Q1 2020 | $33,000 | -15.4% | 61,000 | 0.0% | 0.00% | – |
| Q4 2019 | $39,000 | +77.3% | 61,000 | +77.1% | 0.00% | – |
| Q3 2019 | $22,000 | -33.3% | 34,450 | -8.0% | 0.00% | – |
| Q2 2019 | $33,000 | +17.9% | 37,450 | +15.4% | 0.00% | – |
| Q1 2019 | $28,000 | -34.9% | 32,450 | +27.5% | 0.00% | – |
| Q4 2018 | $43,000 | +10.3% | 25,450 | +96.5% | 0.00% | – |
| Q3 2018 | $39,000 | -25.0% | 12,950 | +3.6% | 0.00% | – |
| Q2 2018 | $52,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 5,621,835 | $7,252,000 | 3.21% |
| Parkman Healthcare Partners LLC | 1,001,189 | $1,292,000 | 0.30% |
| ABG Innovation Capital Partners III GP Ltd | 400,000 | $516,000 | 0.25% |
| Opaleye Management Inc. | 1,000,000 | $1,290,000 | 0.19% |
| EcoR1 Capital, LLC | 2,072,782 | $2,674,000 | 0.12% |
| Ikarian Capital, LLC | 2,651,093 | $3,420,000 | 0.12% |
| Scion Asset Management | 1,000,000 | $1,290,000 | 0.10% |
| Orbimed Advisors | 5,193,946 | $6,700,000 | 0.06% |
| Keudell/Morrison Wealth Management | 30,694 | $40,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 302,949 | $391,000 | 0.02% |